Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation

Abstract The dystroglycanopathies comprise a clinically and genetically heterogeneous group of muscular dystrophies characterized by deficient glycosylation of α-dystroglycan. Mutations in the fukutin ( FKTN ) gene have primarily been identified among patients with classic Fukuyama congenital muscul...

Full description

Saved in:
Bibliographic Details
Published inNeuromuscular disorders : NMD Vol. 19; no. 5; pp. 352 - 356
Main Authors Puckett, Rebecca L, Moore, Steven A, Winder, Thomas L, Willer, Tobias, Romansky, Stephen G, Covault, Kelly King, Campbell, Kevin P, Abdenur, Jose E
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 01.05.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract The dystroglycanopathies comprise a clinically and genetically heterogeneous group of muscular dystrophies characterized by deficient glycosylation of α-dystroglycan. Mutations in the fukutin ( FKTN ) gene have primarily been identified among patients with classic Fukuyama congenital muscular dystrophy (FCMD), a severe form of dystroglycanopathy characterized by CMD, cobblestone lissencephaly and ocular defects. We describe two brothers of Caucasian and Japanese ancestry with normal intelligence and limb-girdle muscular dystrophy (LGMD) due to compound heterozygous FKTN mutations. Muscle biopsy showed a dystrophy with selectively reduced α-dystroglycan glycoepitope immunostaining. Immunoblots revealed hypoglycosylation of α-dystroglycan and loss of laminin binding. FKTN gene sequencing identified two variants: c.340G>A and c.527T>C, predicting missense mutations p.A114T and p.F176S, respectively. Our results provide further evidence for ethnic and allelic heterogeneity and the presence of milder phenotypes in FKTN-dystroglycanopathy despite a substantial degree of α-dystroglycan hypoglycosylation in skeletal muscle.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ObjectType-Article-2
ObjectType-Feature-1
Present address: Prevention Genetics, Marshfield, WI, USA.
ISSN:0960-8966
1873-2364
DOI:10.1016/j.nmd.2009.03.001